FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

38018511000001102: Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Jan 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1147991000001111 Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1148001000001116 Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Is a Gliclazide 60mg modified-release tablets true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Is a Lamzarin true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets Has AMP True Lamzarin 60mg modified-release tablets (Key Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start